Please assess the completion status of the following clinical trial:

Trial Title: High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient must be 18 years of age or older.~* Patients must have either biopsy proven or radiographically suspected non-small cell lung cancer.~* Patients must have disease in the chest that is felt to be surgically resectable.~* ECOG performance status of 0-2.~* Ability to understand and the willingness to sign an IRB-approved informed consent document~Exclusion Criteria:~* Patients younger than 18 years of age~* Women who are pregnant or breast feeding.~* Patients may not be receiving any other investigational agents for the treatment of nonsmall cell lung cancer.~* Patients may not be taking the following medications: high dose vitamin A supplement (multivitamin supplements prohibited only if vitamin A content is greater than 3,500 international units), bexarotene, alitretinoin, tretinoin, adapalene, isotretinoin, acitretin, doxycycline, minocycline, or demeclocycline,~* Uncontrolled intercurrent illness including, but not limited to, pancreatitis, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.~* Hypervitaminosis A - toxic effects of ingesting too much vitamin A.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vitamin A compound (Type: EXPERIMENTAL): Participants receive vitamin A compound PO for 7 consecutive days in the absence of disease progression or unacceptable toxicity. Within 21 days of completing treatment, participants then undergo surgical resection.
- Therapeutic Conventional Surgery (Type: ACTIVE_COMPARATOR): Description Participants undergo surgical resection.

Based on this trial design, predict the completion outcome and termination type (if applicable).